Annual report pursuant to Section 13 and 15(d)

Note 17 - Financial Instruments

v3.10.0.1
Note 17 - Financial Instruments
12 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
(
17
)
Financial Instruments
 
At
June 30, 2017,
$7.3
million of cash equivalents were restricted and classified as a long-term asset. We did
not
hold any restricted cash equivalents at
June 30, 2018.
We did
not
hold any available-for-sale securities at
June 30 2018
and
June 30, 2017.
 
We measure certain assets, including our cost and equity method investments, at fair value on a nonrecurring basis. These assets are recognized at fair value when they are deemed to be other-than-temporarily impaired. During the year ended
June 30, 2018
we did
not
record any other-than-temporary impairments on those assets required to be measured at fair value on a non-recurring basis.